Boehringer Ingelheim renews global technology collaboration agreement with VTU Technology

摘要

Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, have renewed their global Pichia pastoris technology collaboration agreement. VTU Technology, currently offering a very broad and versatile technology platform available for Pichia pastoris protein production, will be responsible for carrying out the joint development program in VTU's facilities in close collaboration between researchers from both companies.Boehringer Ingelheim has decided to prolong their ongoing technology agreement with VTU to further strengthen Pichia's position as a highly attractive and competitive host for the production of biopharmaceuticals.